{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:49:45Z","timestamp":1777099785200,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpba.2026.117519","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:13:46Z","timestamp":1776233626000},"page":"117519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["UHPLC-Orbitrap-HRMS-based metabolite identification and profiling of methylophiopogonone A, A bioactive constituent from Ophiopogon japonicus"],"prefix":"10.1016","volume":"277","author":[{"given":"Yujie","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117519_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jep.2016.01.037","article-title":"Ophiopogon japonicus--a phytochemical, ethnomedicinal and pharmacological review","volume":"181","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jpba.2026.117519_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1248\/cpb.c16-00743","article-title":"Cytotoxic homoisoflavonoids from Ophiopogon japonicus tubers","volume":"65","author":"Dang","year":"2017","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jpba.2026.117519_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154718","article-title":"Ophiopogon japonicus and its active compounds: a review of potential anticancer effects and underlying mechanisms","volume":"113","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jpba.2026.117519_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/jssc.201901222","article-title":"Homoisoflavonoids profiling of Ophiopogon japonicus by off-line coupling high-speed countercurrent chromatography with high-performance liquid chromatography-diode array detector-quadrupole time-of-flight tandem mass spectrometry","volume":"43","author":"Deng","year":"2020","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2026.117519_bib5","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.fitote.2012.05.011","article-title":"Anti-inflammatory homoisoflavonoids from the tuberous roots of Ophiopogon japonicus","volume":"83","author":"Li","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jpba.2026.117519_bib6","first-page":"121","article-title":"Influence of ultrafiltration membrane on ophiopogonins and homoisoflavonoids in Ophiopogon japonicus as measured by ultra-fast liquid chromatography coupled with ion trap time-of-flight mass spectrometry","volume":"15","author":"Liu","year":"2017","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jpba.2026.117519_bib7","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/jssc.200800732","article-title":"An efficient combination of supercritical fluid extraction and high-speed counter-current chromatography to extract and purify homoisoflavonoids from Ophiopogon japonicus (Thunb.) Ker-Gawler","volume":"32","author":"Ma","year":"2009","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2026.117519_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/biom14070785","article-title":"Exploring the antiangiogenic and anti-inflammatory potential of homoisoflavonoids: target identification using biotin probes","volume":"14","author":"Fei","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpba.2026.117519_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1055\/s-0034-1383026","article-title":"Naturally occurring homoisoflavonoids and their pharmacological activities","volume":"80","author":"Lin","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.jpba.2026.117519_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1472-6882-12-238","article-title":"Antimicrobial activities of endophytic fungi isolated from Ophiopogon japonicus (Liliaceae)","volume":"12","author":"Liang","year":"2012","journal-title":"BMC Complement Alter. Med"},{"key":"10.1016\/j.jpba.2026.117519_bib11","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20199201","article-title":"Methylophiopogonanone A, an Ophiopogon homoisoflavonoid, alleviates high-fat diet-induced hyperlipidemia: assessment of its potential mechanism","volume":"53","author":"Li","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jpba.2026.117519_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2408126","article-title":"Active ingredients and action mechanisms of Yi Guan Jian decoction in chronic hepatitis B patients with liver fibrosis","volume":"2019","author":"Li","year":"2019","journal-title":"Evid. Based Complement Altern. Med"},{"key":"10.1016\/j.jpba.2026.117519_bib13","article-title":"silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis","volume":"26","author":"Harisna","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.jpba.2026.117519_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103621","article-title":"Preclinical evaluation of chemically reactive metabolites and mitigation of bioactivation in drug discovery","volume":"28","author":"He","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2026.117519_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/03602532.2024.2313967","article-title":"Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity","volume":"56","author":"Khalil","year":"2024","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpba.2026.117519_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2005.03.036","article-title":"Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and recombinant P4503A4","volume":"155","author":"Kalgutkar","year":"2005","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jpba.2026.117519_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4062\/biomolther.2017.225","article-title":"Fasiglifam (TAK-875), a G protein-coupled receptor 40 (GPR40) agonist, may induce hepatotoxicity through reactive oxygen species generation in a GPR40-dependent manner","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.jpba.2026.117519_bib18","unstructured":"Food and Drug Administration, Safety Testing of Drug Metabolites, Guidance for Industry, 2020; Available at: https:\/\/www.fda.gov\/media\/72279\/download."},{"key":"10.1016\/j.jpba.2026.117519_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/17425255.2018.1519546","article-title":"Drug metabolism and metabolite safety assessment in drug discovery and development","volume":"14","author":"He","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2026.117519_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/03602532.2022.2144879","article-title":"Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development","volume":"54","author":"Gajula","year":"2022","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpba.2026.117519_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2026.117519_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9959","article-title":"Detection and identification of new chlorphenesin carbamate metabolites in human urine and metabolomic characterization using liquid chromatography-Q Exactive-HF-Orbitrap mass spectrometry","volume":"39","author":"Xu","year":"2025","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2026.117519_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/17460441.2019.1582638","article-title":"Liquid chromatography coupled to mass spectrometry for metabolite profiling in the field of drug discovery","volume":"14","author":"Saurina","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jpba.2026.117519_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116388","article-title":"Metabolic profiling of different parts of Physalis alkekengi L. var. franchetii (Mast.) Makino based on UPLC-Q-Orbitrap-HRMS coupled with bioactivity assays","volume":"249","author":"Zhang","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117519_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2026.117357","article-title":"Identification of metabolites from the Himalayan herbal medicine Meconopsis integrifolia total flavonoids fraction in rats using UPLC-Q-exactive orbitrap-MS analysis","volume":"272","author":"Ji","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117519_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.339814","article-title":"Mass defect filter technique combined with stable isotope tracing for drug metabolite identification using high-resolution mass spectrometry","volume":"1208","author":"Su","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2026.117519_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9881","article-title":"Structural elucidation of tramadol, its derivatives, and metabolites using chemical derivatization and liquid chromatography-high-resolution tandem mass spectrometry","volume":"38","author":"Shamai Yamin","year":"2024","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2026.117519_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9846","article-title":"Characterizing lomerizine metabolites in camel urine: high-resolution mass spectrometry method development and validation for enhanced doping control","volume":"38","author":"Nalakath","year":"2024","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2026.117519_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpba.2026.117519_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/03602532.2025.2472076","article-title":"In-depth understanding of the structure-based reactive metabolite formation of organic functional groups","volume":"57","author":"He","year":"2025","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpba.2026.117519_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9304","article-title":"Identification of the metabolites of methylophiopogonanone A by ultra-high-performance liquid chromatography combined with high-resolution mass spectrometry","volume":"36","author":"Wu","year":"2022","journal-title":"Rapid Commun. Mass Spectrom."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:16:19Z","timestamp":1777097779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0731708526001871"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117519","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UHPLC-Orbitrap-HRMS-based metabolite identification and profiling of methylophiopogonone A, A bioactive constituent from Ophiopogon japonicus","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117519"}}